If the problem is desire rather than mechanics, brain-acting peptides are the appropriate tool
The most common side effects are
Ruggiero R, Mascolo A, Spezzaferri A, Carpentieri C, Torella D, Sportiello L, et al
In a diverse array of animal and cell-based models of neurological disorders, semaglutide has exhibited distinct protective effects, providing a biological rationale for its exploration in human studies
Semaglutide and tirzepatide products have different indications, dosing schedules, contraindications, warnings, and side-effect profiles
The latter one which included 4 trials (43,456 patients) suggested that GLP-1 RAs reduced MACE by 13% (HR 0.87, 95% CI 0.820.93), an effect which was consistent in both subgroups (HR 0.91, 95% CI 0.850.97 and HR 0.80, 95% CI 0.720.90 with and without metformin, respectively)